Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates

NCT00208039 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2007-11-22

No results posted yet for this study

Summary

A research study that will evaluate if giving surfactant medication to premature babies weighing \< 1250 gm at birth during the second and third weeks of life will help their lungs. We are enrolling those premature babies who continue to require the breathing tube and the mechanical ventilator at days 7-10 of life.

Conditions

Respiratory Distress Syndrome
Bronchopulmonary Dysplasia

Interventions

DRUG

Infasurf

Infasurf 3 cc/kg instilled via endotracheal tube, repeated 3 and 7 days later if infant stable and continues to meet criteria

Principal Investigators

Michael Posencheg, MD · University of Pennsylvania/Children's Hospital of Philadelphia
Roberta A Ballard, MD · University of California, San Francisco Medical Center

Study Design

Allocation: NON_RANDOMIZED
Purpose: TREATMENT
Masking: NONE
Model: SINGLE_GROUP

Eligibility

Min Age: 7 Days
Max Age: 10 Days
Sex: ALL
Healthy Volunteers: No

Timeline & Regulatory

Start: 2004-09-30
Completion: 2007-11-30

More Related Trials

Entities

Companies

Summary

Conditions

Interventions

Sponsors & Collaborators

Principal Investigators

Study Design

Eligibility

Timeline & Regulatory

Related Clinical Trials

Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation

Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide

Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia

Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)

Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study

More Related Trials

Entities